how to join retatrutide trial The numbers from Lilly's Phase 3 dropped this week and I haven't been able stop thinking about them. Not only as a doctor but as a long-term GLP-1 user eli lilly phase 3 trial
Description
Follow for more updates just like this | 17 comments on LinkedIn
People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering over 9,000 individuals showed.
placebo (p<0.001), the effect was greatest in subjects with eGFR>60 ml/min/1.73 m2
With consistent use, expect appetite control, improved mood and metabolic regularity by week 4 backed by science
